推荐应用
Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'-linked polyubiquitination. Cooperates with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Ubiquitin chain elongation is then performed by CDC34, building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. Acts also as an initiator E2, in conjunction with RNF8, for the priming of PCNA. Monoubiquitination of PCNA, and its subsequent polyubiquitination, are essential events in the operation of the DNA damage tolerance (DDT) pathway that is activated after DNA damage caused by UV or chemical agents during S-phase. Associates with the BRCA1/BARD1 E3 ligase complex to perform ubiquitination at DNA damage sites following ionizing radiation leading to DNA repair. Targets DAPK3 for ubiquitination which influences promyelocytic leukemia protein nuclear body (PML-NB) formation in the nucleus. In conjunction with the MDM2 and TOPORS E3 ligases, functions ubiquitination of p53/TP53. Supports NRDP1-mediated ubiquitination and degradation of ERBB3 and of BRUCE which triggers apoptosis. In conjunction with the CBL E3 ligase, targets EGFR for polyubiquitination at the plasma membrane as well as during its internalization and transport on endosomes. In conjunction with the STUB1 E3 quality control E3 ligase, ubiquitinates unfolded proteins to catalyze their immediate destruction.
推荐稀释比 WB:1/500-1/1000;IP:1/20

Western blot analysis of UBE2D3 in K562, rat Brain, C6, 3T3, Hela lysates using Ubiquitin Conjugating Enzyme E2 D3 antibody.
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【应用方向】单细胞表观测序中的抗体应用
306
2026-07-29
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
685
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
516
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
523
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
500
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
511
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
454
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
482
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
531
2026-07-21
【应用方向】心肌再生研究与抗体应用解决方案——助力心血管修复机制解析
13900
2026-03-18
【应用方向】抗体应用研究——心肌纤维化解析
20598
2026-04-14
【技术讲解】抗体赋能心肌梗死研究—精准靶向,助力科研突破
7516
2026-04-14
【应用方向】抗体应用研究—心肌发育的分子解析与前沿转化
15201
2026-04-14
【应用方向】抗体应用研究—细胞死亡
20463
2026-07-16
【应用方向】经典信号通路-JAK/STAT信号转导通路及抗体推荐
13384
2026-04-14





